
The Cooper Companies COO
$ 64.42
-0.82%
Quarterly report 2025-Q4
added 03-06-2026
The Cooper Companies Accounts Payables 2011-2026 | COO
Accounts payable — are the obligations of an organization to other legal entities or individuals that arise in cases when the company has acquired goods or services on deferred payment terms, has not paid taxes and fees, has wage arrears to employees, or has received loans and other liabilities. Accounts payable arise when an organization has already received some benefit but has not yet paid for it.Main types of accounts payable
| Type of liability | Example |
|---|---|
| To suppliers and contractors | Goods received but not yet paid for |
| Taxes and fees | VAT, income tax, etc., not paid on time |
| Salaries | Employee wages not paid |
| To budgets | Insurance contributions to funds not paid |
| To founders | Founders provided borrowed funds |
| To banks | Overdue loan payments |
| Other | Fines, penalties, forfeits, customer prepayments, etc. |
Impact on the company's financial performance
- Liquidity and solvency
Accounts payable are part of short-term liabilities, so they affect liquidity ratios - Financial stability
The higher the share of borrowed funds (including accounts payable), the lower the company's level of independence - Capital turnover
Moderate accounts payable can positively affect working capital by allowing the company to use “free” financing from suppliers (payment deferrals) - Risks and reputation
Large and especially overdue accounts payable may indicate financial difficulties. This can deter investors, partners, and lenders, and at a critical level of debt and lack of resources to repay it, bankruptcy proceedings may be initiated
Annual Accounts Payables The Cooper Companies
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 300 M | 260 M | 262 M | 249 M | 161 M | 176 M | 150 M | 146 M | 142 M | 107 M | 117 M | 116 M | 108 M | 85.1 M | 61.8 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 300 M | 61.8 M | 163 M |
Quarterly Accounts Payables The Cooper Companies
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 226 M | 300 M | 256 M | 244 M | 202 M | 260 M | 222 M | 231 M | 202 M | 262 M | 227 M | 242 M | 149 M | 249 M | 227 M | 184 M | 137 M | 161 M | 153 M | 161 M | 142 M | 176 M | 176 M | 176 M | 130 M | 150 M | 150 M | 150 M | 108 M | 146 M | 146 M | 146 M | 100 M | 142 M | 142 M | 142 M | 116 M | 107 M | 107 M | 107 M | 87.3 M | 117 M | 117 M | 117 M | 74.8 M | 116 M | 116 M | 116 M | 61.9 M | 108 M | 108 M | 108 M | 48.2 M | 85.1 M | 85.1 M | 85.1 M | 48.3 M | 61.8 M | 61.8 M | 61.8 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 300 M | 48.2 M | 147 M |
Accounts Payables of other stocks in the Medical instruments industry
| Issuer | Accounts Payables | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
6.63 K | - | - | $ 810 M | ||
|
iRhythm Technologies
IRTC
|
2.26 M | $ 122.35 | 0.73 % | $ 3.92 B | ||
|
Repro Med Systems
KRMD
|
2.27 M | $ 3.96 | -0.75 % | $ 183 M | ||
|
Ekso Bionics Holdings
EKSO
|
1.43 M | $ 10.99 | 1.48 % | $ 26.7 M | ||
|
Haemonetics Corporation
HAE
|
67 M | $ 59.93 | 0.52 % | $ 3.02 B | ||
|
electroCore
ECOR
|
2.71 M | $ 6.18 | -0.08 % | $ 52.4 K | ||
|
ICU Medical
ICUI
|
154 M | $ 124.82 | 0.22 % | $ 3.08 B | ||
|
Envista Holdings Corporation
NVST
|
192 M | $ 26.8 | -0.89 % | $ 4.5 B | ||
|
Intuitive Surgical
ISRG
|
255 M | $ 482.22 | 0.71 % | $ 172 B | ||
|
Pulse Biosciences
PLSE
|
2.78 M | $ 23.02 | -5.07 % | $ 1.55 B | ||
|
Glaukos Corporation
GKOS
|
13.4 M | $ 121.48 | 0.5 % | $ 5.88 B | ||
|
Microbot Medical
MBOT
|
511 K | $ 2.2 | 0.92 % | $ 101 M | ||
|
STAAR Surgical Company
STAA
|
11.6 M | $ 25.67 | 3.34 % | $ 1.27 B | ||
|
STERIS plc
STE
|
281 M | $ 221.8 | -0.77 % | $ 21.9 B | ||
|
Masimo Corporation
MASI
|
253 M | $ 178.63 | -0.04 % | $ 9.52 B | ||
|
Milestone Scientific
MLSS
|
780 K | $ 0.32 | -1.27 % | $ 26.3 M | ||
|
InfuSystem Holdings
INFU
|
8.34 M | $ 10.34 | 0.68 % | $ 214 M | ||
|
Stereotaxis
STXS
|
4.77 M | $ 1.93 | -1.53 % | $ 176 M | ||
|
Merit Medical Systems
MMSI
|
60.6 M | $ 68.58 | -0.04 % | $ 4.06 B | ||
|
Teleflex Incorporated
TFX
|
130 M | $ 136.56 | -0.07 % | $ 6.09 B | ||
|
Utah Medical Products
UTMD
|
911 K | $ 67.17 | -1.03 % | $ 218 M | ||
|
West Pharmaceutical Services
WST
|
254 M | $ 306.16 | -1.14 % | $ 22.1 B | ||
|
DENTSPLY SIRONA
XRAY
|
300 M | $ 11.91 | 0.08 % | $ 2.37 B | ||
|
Retractable Technologies
RVP
|
5.34 M | $ 0.65 | 0.2 % | $ 19.5 M | ||
|
Pro-Dex
PDEX
|
4.61 M | $ 52.1 | 2.24 % | $ 171 M | ||
|
LeMaitre Vascular
LMAT
|
3.65 M | $ 113.45 | 0.49 % | $ 2.57 B | ||
|
Predictive Oncology
POAI
|
1.84 M | - | - | $ 31.1 M | ||
|
BioLife Solutions
BLFS
|
3.57 M | $ 21.38 | -1.57 % | $ 985 M | ||
|
Baxter International
BAX
|
999 M | $ 18.16 | -1.39 % | $ 9.32 B | ||
|
ResMed
RMD
|
159 M | $ 219.85 | 0.15 % | $ 32.1 B | ||
|
AtriCure
ATRC
|
25.3 M | $ 29.28 | 3.79 % | $ 1.4 B | ||
|
Harvard Bioscience
HBIO
|
3.65 M | $ 6.86 | 1.18 % | $ 305 M | ||
|
NeuroMetrix
NURO
|
363 K | - | 5.05 % | $ 9.02 M | ||
|
AngioDynamics
ANGO
|
33.3 M | $ 11.1 | -0.89 % | $ 453 M | ||
|
Becton, Dickinson and Company
BDX
|
1.97 B | $ 152.14 | -1.74 % | $ 43.8 B | ||
|
Nephros
NEPH
|
873 K | $ 2.87 | 1.06 % | $ 29.8 M | ||
|
OraSure Technologies
OSUR
|
6.52 M | $ 3.0 | -1.64 % | $ 220 M | ||
|
Repligen Corporation
RGEN
|
19.6 M | $ 117.6 | 3.1 % | $ 6.55 M |